240 related articles for article (PubMed ID: 35663961)
1. Functions of IFNλs in Anti-Bacterial Immunity at Mucosal Barriers.
Alphonse N; Dickenson RE; Alrehaili A; Odendall C
Front Immunol; 2022; 13():857639. PubMed ID: 35663961
[TBL] [Abstract][Full Text] [Related]
2. Lambda interferons in immunity and autoimmunity.
Vlachiotis S; Andreakos E
J Autoimmun; 2019 Nov; 104():102319. PubMed ID: 31481283
[TBL] [Abstract][Full Text] [Related]
3. IFNλ: balancing the light and dark side in pulmonary infection.
Antos D; Alcorn JF
mBio; 2023 Aug; 14(4):e0285022. PubMed ID: 37278532
[TBL] [Abstract][Full Text] [Related]
4. Type III interferons in innate and adaptive immunity in the respiratory tract.
Piperakis A; Galani IE; Andreakos E
Curr Opin Immunol; 2024 Apr; 87():102430. PubMed ID: 38824869
[TBL] [Abstract][Full Text] [Related]
5. Lambda interferons come to light: dual function cytokines mediating antiviral immunity and damage control.
Andreakos E; Zanoni I; Galani IE
Curr Opin Immunol; 2019 Feb; 56():67-75. PubMed ID: 30399529
[TBL] [Abstract][Full Text] [Related]
6. Interferon Lambda Genetics and Biology in Regulation of Viral Control.
Hemann EA; Gale M; Savan R
Front Immunol; 2017; 8():1707. PubMed ID: 29270173
[TBL] [Abstract][Full Text] [Related]
7. The unique regulation and functions of type III interferons in antiviral immunity.
Odendall C; Kagan JC
Curr Opin Virol; 2015 Jun; 12():47-52. PubMed ID: 25771505
[TBL] [Abstract][Full Text] [Related]
8. Interferon-λ Mediates Non-redundant Front-Line Antiviral Protection against Influenza Virus Infection without Compromising Host Fitness.
Galani IE; Triantafyllia V; Eleminiadou EE; Koltsida O; Stavropoulos A; Manioudaki M; Thanos D; Doyle SE; Kotenko SV; Thanopoulou K; Andreakos E
Immunity; 2017 May; 46(5):875-890.e6. PubMed ID: 28514692
[TBL] [Abstract][Full Text] [Related]
9. Type III IFNs: Beyond antiviral protection.
Kotenko SV; Rivera A; Parker D; Durbin JE
Semin Immunol; 2019 Jun; 43():101303. PubMed ID: 31771761
[TBL] [Abstract][Full Text] [Related]
10. Macrophages and neutrophils express IFNλs in granulomas from
Talukdar P; Junecko BF; Lane DS; Maiello P; Mattila JT
Front Immunol; 2022; 13():985405. PubMed ID: 36189279
[TBL] [Abstract][Full Text] [Related]
11. Interferon-λs: Front-Line Guardians of Immunity and Homeostasis in the Respiratory Tract.
Andreakos E; Salagianni M; Galani IE; Koltsida O
Front Immunol; 2017; 8():1232. PubMed ID: 29033947
[TBL] [Abstract][Full Text] [Related]
12. Roles and Effects of Interferon Lambda Signaling in the Context of Bacterial Infections.
Johnson D; Carbonetti N
J Interferon Cytokine Res; 2023 Sep; 43(9):363-369. PubMed ID: 37289801
[TBL] [Abstract][Full Text] [Related]
13. Interferon lambda in inflammation and autoimmune rheumatic diseases.
Goel RR; Kotenko SV; Kaplan MJ
Nat Rev Rheumatol; 2021 Jun; 17(6):349-362. PubMed ID: 33907323
[TBL] [Abstract][Full Text] [Related]
14. Type I and Type III Interferons Display Different Dependency on Mitogen-Activated Protein Kinases to Mount an Antiviral State in the Human Gut.
Pervolaraki K; Stanifer ML; Münchau S; Renn LA; Albrecht D; Kurzhals S; Senís E; Grimm D; Schröder-Braunstein J; Rabin RL; Boulant S
Front Immunol; 2017; 8():459. PubMed ID: 28484457
[TBL] [Abstract][Full Text] [Related]
15. Type III interferon induces apoptosis in human lung cancer cells.
Li W; Huang X; Liu Z; Wang Y; Zhang H; Tong H; Wu H; Lin S
Oncol Rep; 2012 Sep; 28(3):1117-25. PubMed ID: 22766785
[TBL] [Abstract][Full Text] [Related]
16. Selective Interferon Responses of Intestinal Epithelial Cells Minimize Tumor Necrosis Factor Alpha Cytotoxicity.
Van Winkle JA; Constant DA; Li L; Nice TJ
J Virol; 2020 Oct; 94(21):. PubMed ID: 32847859
[TBL] [Abstract][Full Text] [Related]
17. Differential signaling by type-I and type-III interferons in mucosa.
Stanifer ML; Boulant S
Curr Opin Immunol; 2024 Feb; 86():102400. PubMed ID: 38118395
[TBL] [Abstract][Full Text] [Related]
18. Interferon lambda 4 can directly activate human CD19
Coto-Llerena M; Lepore M; Spagnuolo J; Di Blasi D; Calabrese D; Suslov A; Bantug G; Duong FH; Terracciano LM; De Libero G; Heim MH
Life Sci Alliance; 2021 Jan; 4(1):. PubMed ID: 33158978
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Type III Interferon Expression in Intestinal Epithelial Cells-A Strategy Used by Coxsackie B Virus to Evade the Host's Innate Immune Response at the Primary Site of Infection?
Stone VM; Ringqvist EE; Larsson PG; Domsgen E; Holmlund U; Sverremark-Ekström E; Flodström-Tullberg M
Microorganisms; 2021 Jan; 9(1):. PubMed ID: 33466313
[TBL] [Abstract][Full Text] [Related]
20. Interferon-λs and Plasmacytoid Dendritic Cells: A Close Relationship.
Finotti G; Tamassia N; Cassatella MA
Front Immunol; 2017; 8():1015. PubMed ID: 28878776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
